Furthermore, another study published shortly after sought to evaluate the association among antidiabetic regimens and cancer-related mortality in T2DM patients, hypothesizing that the modifications of insulin levels induced by these different agents might have a role in promoting or inhibiting cancer [18]. This evidence concerns the gene INS and cancer.